外科用止血材のグローバル市場展望 2023年-2029年:止血ガーゼ、ゼラチンスポンジ、止血剤

■ 英語タイトル:Surgical Hemostatic Material Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート(データ管理コード:MMG23LY8064)■ 発行会社/調査会社:Market Monitor Global
■ 商品コード:MMG23LY8064
■ 発行日:2023年7月
■ 調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野:医療機器&消耗品
■ ページ数:117
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後2-3営業日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[外科用止血材のグローバル市場展望 2023年-2029年:止血ガーゼ、ゼラチンスポンジ、止血剤]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

当調査レポートは次の情報を含め、世界の外科用止血材市場規模と予測を収録しています。・世界の外科用止血材市場:売上、2018年-2023年、2024年-2029年
・世界の外科用止血材市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の外科用止血材市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「止血ガーゼ」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

外科用止血材のグローバル主要企業は、Johnson & Johnson、 BD、 Baxter、 B.Braun、 Cura Medical、 GELITA MEDICAL、 Curasan AG、 Meril Life Sciences、 Zhonghui Shengxi、 Beijing Datsing Bio-tech、 Guizhou Jin Jiu Biotech、 Beijing Taikesiman、 Foryou Medical、 Saikesaisi Holdings Group、 Biotemed、 Hangzhou Singclean Medical Productsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、外科用止血材のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の外科用止血材市場:タイプ別、2018年-2023年、2024年-2029年
世界の外科用止血材市場:タイプ別市場シェア、2022年
・止血ガーゼ、ゼラチンスポンジ、止血剤

世界の外科用止血材市場:用途別、2018年-2023年、2024年-2029年
世界の外科用止血材市場:用途別市場シェア、2022年
・病院、診療所、その他

世界の外科用止血材市場:地域・国別、2018年-2023年、2024年-2029年
世界の外科用止血材市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における外科用止血材のグローバル売上、2018年-2023年
・主要企業における外科用止血材のグローバル売上シェア、2022年
・主要企業における外科用止血材のグローバル販売量、2018年-2023年
・主要企業における外科用止血材のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Johnson & Johnson、 BD、 Baxter、 B.Braun、 Cura Medical、 GELITA MEDICAL、 Curasan AG、 Meril Life Sciences、 Zhonghui Shengxi、 Beijing Datsing Bio-tech、 Guizhou Jin Jiu Biotech、 Beijing Taikesiman、 Foryou Medical、 Saikesaisi Holdings Group、 Biotemed、 Hangzhou Singclean Medical Products

*************************************************************

・調査・分析レポートの概要
外科用止血材市場の定義
市場セグメント
世界の外科用止血材市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の外科用止血材市場規模
世界の外科用止血材市場規模:2022年 VS 2029年
世界の外科用止血材市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの外科用止血材の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の外科用止血材製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:止血ガーゼ、ゼラチンスポンジ、止血剤
外科用止血材のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、診療所、その他
外科用止血材の用途別グローバル売上・予測

・地域別市場分析
地域別外科用止血材市場規模 2022年と2029年
地域別外科用止血材売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Johnson & Johnson、 BD、 Baxter、 B.Braun、 Cura Medical、 GELITA MEDICAL、 Curasan AG、 Meril Life Sciences、 Zhonghui Shengxi、 Beijing Datsing Bio-tech、 Guizhou Jin Jiu Biotech、 Beijing Taikesiman、 Foryou Medical、 Saikesaisi Holdings Group、 Biotemed、 Hangzhou Singclean Medical Products
...

Surgical hemostatic material is used to control bleeding intraoperatively.
This report aims to provide a comprehensive presentation of the global market for Surgical Hemostatic Material, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Surgical Hemostatic Material. This report contains market size and forecasts of Surgical Hemostatic Material in global, including the following market information:
Global Surgical Hemostatic Material Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Surgical Hemostatic Material Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Surgical Hemostatic Material companies in 2022 (%)
The global Surgical Hemostatic Material market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Hemostatic Gauze Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Surgical Hemostatic Material include Johnson & Johnson, BD, Baxter, B.Braun, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences and Zhonghui Shengxi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Surgical Hemostatic Material manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Surgical Hemostatic Material Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Surgical Hemostatic Material Market Segment Percentages, by Type, 2022 (%)
Hemostatic Gauze
Gelatin Sponge
Styptic Powder
Global Surgical Hemostatic Material Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Surgical Hemostatic Material Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Surgical Hemostatic Material Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Surgical Hemostatic Material Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Surgical Hemostatic Material revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Surgical Hemostatic Material revenues share in global market, 2022 (%)
Key companies Surgical Hemostatic Material sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Surgical Hemostatic Material sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
BD
Baxter
B.Braun
Cura Medical
GELITA MEDICAL
Curasan AG
Meril Life Sciences
Zhonghui Shengxi
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Beijing Taikesiman
Foryou Medical
Saikesaisi Holdings Group
Biotemed
Hangzhou Singclean Medical Products
Outline of Major Chapters:
Chapter 1: Introduces the definition of Surgical Hemostatic Material, market overview.
Chapter 2: Global Surgical Hemostatic Material market size in revenue and volume.
Chapter 3: Detailed analysis of Surgical Hemostatic Material manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Surgical Hemostatic Material in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Surgical Hemostatic Material capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次(コンテンツ)***

1 Introduction to Research & Analysis Reports
1.1 Surgical Hemostatic Material Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Surgical Hemostatic Material Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Surgical Hemostatic Material Overall Market Size
2.1 Global Surgical Hemostatic Material Market Size: 2022 VS 2029
2.2 Global Surgical Hemostatic Material Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Surgical Hemostatic Material Sales: 2018-2029
3 Company Landscape
3.1 Top Surgical Hemostatic Material Players in Global Market
3.2 Top Global Surgical Hemostatic Material Companies Ranked by Revenue
3.3 Global Surgical Hemostatic Material Revenue by Companies
3.4 Global Surgical Hemostatic Material Sales by Companies
3.5 Global Surgical Hemostatic Material Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Surgical Hemostatic Material Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Surgical Hemostatic Material Product Type
3.8 Tier 1, Tier 2 and Tier 3 Surgical Hemostatic Material Players in Global Market
3.8.1 List of Global Tier 1 Surgical Hemostatic Material Companies
3.8.2 List of Global Tier 2 and Tier 3 Surgical Hemostatic Material Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Surgical Hemostatic Material Market Size Markets, 2022 & 2029
4.1.2 Hemostatic Gauze
4.1.3 Gelatin Sponge
4.1.4 Styptic Powder
4.2 By Type – Global Surgical Hemostatic Material Revenue & Forecasts
4.2.1 By Type – Global Surgical Hemostatic Material Revenue, 2018-2023
4.2.2 By Type – Global Surgical Hemostatic Material Revenue, 2024-2029
4.2.3 By Type – Global Surgical Hemostatic Material Revenue Market Share, 2018-2029
4.3 By Type – Global Surgical Hemostatic Material Sales & Forecasts
4.3.1 By Type – Global Surgical Hemostatic Material Sales, 2018-2023
4.3.2 By Type – Global Surgical Hemostatic Material Sales, 2024-2029
4.3.3 By Type – Global Surgical Hemostatic Material Sales Market Share, 2018-2029
4.4 By Type – Global Surgical Hemostatic Material Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Surgical Hemostatic Material Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Surgical Hemostatic Material Revenue & Forecasts
5.2.1 By Application – Global Surgical Hemostatic Material Revenue, 2018-2023
5.2.2 By Application – Global Surgical Hemostatic Material Revenue, 2024-2029
5.2.3 By Application – Global Surgical Hemostatic Material Revenue Market Share, 2018-2029
5.3 By Application – Global Surgical Hemostatic Material Sales & Forecasts
5.3.1 By Application – Global Surgical Hemostatic Material Sales, 2018-2023
5.3.2 By Application – Global Surgical Hemostatic Material Sales, 2024-2029
5.3.3 By Application – Global Surgical Hemostatic Material Sales Market Share, 2018-2029
5.4 By Application – Global Surgical Hemostatic Material Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Surgical Hemostatic Material Market Size, 2022 & 2029
6.2 By Region – Global Surgical Hemostatic Material Revenue & Forecasts
6.2.1 By Region – Global Surgical Hemostatic Material Revenue, 2018-2023
6.2.2 By Region – Global Surgical Hemostatic Material Revenue, 2024-2029
6.2.3 By Region – Global Surgical Hemostatic Material Revenue Market Share, 2018-2029
6.3 By Region – Global Surgical Hemostatic Material Sales & Forecasts
6.3.1 By Region – Global Surgical Hemostatic Material Sales, 2018-2023
6.3.2 By Region – Global Surgical Hemostatic Material Sales, 2024-2029
6.3.3 By Region – Global Surgical Hemostatic Material Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Surgical Hemostatic Material Revenue, 2018-2029
6.4.2 By Country – North America Surgical Hemostatic Material Sales, 2018-2029
6.4.3 US Surgical Hemostatic Material Market Size, 2018-2029
6.4.4 Canada Surgical Hemostatic Material Market Size, 2018-2029
6.4.5 Mexico Surgical Hemostatic Material Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Surgical Hemostatic Material Revenue, 2018-2029
6.5.2 By Country – Europe Surgical Hemostatic Material Sales, 2018-2029
6.5.3 Germany Surgical Hemostatic Material Market Size, 2018-2029
6.5.4 France Surgical Hemostatic Material Market Size, 2018-2029
6.5.5 U.K. Surgical Hemostatic Material Market Size, 2018-2029
6.5.6 Italy Surgical Hemostatic Material Market Size, 2018-2029
6.5.7 Russia Surgical Hemostatic Material Market Size, 2018-2029
6.5.8 Nordic Countries Surgical Hemostatic Material Market Size, 2018-2029
6.5.9 Benelux Surgical Hemostatic Material Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Surgical Hemostatic Material Revenue, 2018-2029
6.6.2 By Region – Asia Surgical Hemostatic Material Sales, 2018-2029
6.6.3 China Surgical Hemostatic Material Market Size, 2018-2029
6.6.4 Japan Surgical Hemostatic Material Market Size, 2018-2029
6.6.5 South Korea Surgical Hemostatic Material Market Size, 2018-2029
6.6.6 Southeast Asia Surgical Hemostatic Material Market Size, 2018-2029
6.6.7 India Surgical Hemostatic Material Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Surgical Hemostatic Material Revenue, 2018-2029
6.7.2 By Country – South America Surgical Hemostatic Material Sales, 2018-2029
6.7.3 Brazil Surgical Hemostatic Material Market Size, 2018-2029
6.7.4 Argentina Surgical Hemostatic Material Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Surgical Hemostatic Material Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Surgical Hemostatic Material Sales, 2018-2029
6.8.3 Turkey Surgical Hemostatic Material Market Size, 2018-2029
6.8.4 Israel Surgical Hemostatic Material Market Size, 2018-2029
6.8.5 Saudi Arabia Surgical Hemostatic Material Market Size, 2018-2029
6.8.6 UAE Surgical Hemostatic Material Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Surgical Hemostatic Material Major Product Offerings
7.1.4 Johnson & Johnson Surgical Hemostatic Material Sales and Revenue in Global (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 BD
7.2.1 BD Company Summary
7.2.2 BD Business Overview
7.2.3 BD Surgical Hemostatic Material Major Product Offerings
7.2.4 BD Surgical Hemostatic Material Sales and Revenue in Global (2018-2023)
7.2.5 BD Key News & Latest Developments
7.3 Baxter
7.3.1 Baxter Company Summary
7.3.2 Baxter Business Overview
7.3.3 Baxter Surgical Hemostatic Material Major Product Offerings
7.3.4 Baxter Surgical Hemostatic Material Sales and Revenue in Global (2018-2023)
7.3.5 Baxter Key News & Latest Developments
7.4 B.Braun
7.4.1 B.Braun Company Summary
7.4.2 B.Braun Business Overview
7.4.3 B.Braun Surgical Hemostatic Material Major Product Offerings
7.4.4 B.Braun Surgical Hemostatic Material Sales and Revenue in Global (2018-2023)
7.4.5 B.Braun Key News & Latest Developments
7.5 Cura Medical
7.5.1 Cura Medical Company Summary
7.5.2 Cura Medical Business Overview
7.5.3 Cura Medical Surgical Hemostatic Material Major Product Offerings
7.5.4 Cura Medical Surgical Hemostatic Material Sales and Revenue in Global (2018-2023)
7.5.5 Cura Medical Key News & Latest Developments
7.6 GELITA MEDICAL
7.6.1 GELITA MEDICAL Company Summary
7.6.2 GELITA MEDICAL Business Overview
7.6.3 GELITA MEDICAL Surgical Hemostatic Material Major Product Offerings
7.6.4 GELITA MEDICAL Surgical Hemostatic Material Sales and Revenue in Global (2018-2023)
7.6.5 GELITA MEDICAL Key News & Latest Developments
7.7 Curasan AG
7.7.1 Curasan AG Company Summary
7.7.2 Curasan AG Business Overview
7.7.3 Curasan AG Surgical Hemostatic Material Major Product Offerings
7.7.4 Curasan AG Surgical Hemostatic Material Sales and Revenue in Global (2018-2023)
7.7.5 Curasan AG Key News & Latest Developments
7.8 Meril Life Sciences
7.8.1 Meril Life Sciences Company Summary
7.8.2 Meril Life Sciences Business Overview
7.8.3 Meril Life Sciences Surgical Hemostatic Material Major Product Offerings
7.8.4 Meril Life Sciences Surgical Hemostatic Material Sales and Revenue in Global (2018-2023)
7.8.5 Meril Life Sciences Key News & Latest Developments
7.9 Zhonghui Shengxi
7.9.1 Zhonghui Shengxi Company Summary
7.9.2 Zhonghui Shengxi Business Overview
7.9.3 Zhonghui Shengxi Surgical Hemostatic Material Major Product Offerings
7.9.4 Zhonghui Shengxi Surgical Hemostatic Material Sales and Revenue in Global (2018-2023)
7.9.5 Zhonghui Shengxi Key News & Latest Developments
7.10 Beijing Datsing Bio-tech
7.10.1 Beijing Datsing Bio-tech Company Summary
7.10.2 Beijing Datsing Bio-tech Business Overview
7.10.3 Beijing Datsing Bio-tech Surgical Hemostatic Material Major Product Offerings
7.10.4 Beijing Datsing Bio-tech Surgical Hemostatic Material Sales and Revenue in Global (2018-2023)
7.10.5 Beijing Datsing Bio-tech Key News & Latest Developments
7.11 Guizhou Jin Jiu Biotech
7.11.1 Guizhou Jin Jiu Biotech Company Summary
7.11.2 Guizhou Jin Jiu Biotech Surgical Hemostatic Material Business Overview
7.11.3 Guizhou Jin Jiu Biotech Surgical Hemostatic Material Major Product Offerings
7.11.4 Guizhou Jin Jiu Biotech Surgical Hemostatic Material Sales and Revenue in Global (2018-2023)
7.11.5 Guizhou Jin Jiu Biotech Key News & Latest Developments
7.12 Beijing Taikesiman
7.12.1 Beijing Taikesiman Company Summary
7.12.2 Beijing Taikesiman Surgical Hemostatic Material Business Overview
7.12.3 Beijing Taikesiman Surgical Hemostatic Material Major Product Offerings
7.12.4 Beijing Taikesiman Surgical Hemostatic Material Sales and Revenue in Global (2018-2023)
7.12.5 Beijing Taikesiman Key News & Latest Developments
7.13 Foryou Medical
7.13.1 Foryou Medical Company Summary
7.13.2 Foryou Medical Surgical Hemostatic Material Business Overview
7.13.3 Foryou Medical Surgical Hemostatic Material Major Product Offerings
7.13.4 Foryou Medical Surgical Hemostatic Material Sales and Revenue in Global (2018-2023)
7.13.5 Foryou Medical Key News & Latest Developments
7.14 Saikesaisi Holdings Group
7.14.1 Saikesaisi Holdings Group Company Summary
7.14.2 Saikesaisi Holdings Group Business Overview
7.14.3 Saikesaisi Holdings Group Surgical Hemostatic Material Major Product Offerings
7.14.4 Saikesaisi Holdings Group Surgical Hemostatic Material Sales and Revenue in Global (2018-2023)
7.14.5 Saikesaisi Holdings Group Key News & Latest Developments
7.15 Biotemed
7.15.1 Biotemed Company Summary
7.15.2 Biotemed Business Overview
7.15.3 Biotemed Surgical Hemostatic Material Major Product Offerings
7.15.4 Biotemed Surgical Hemostatic Material Sales and Revenue in Global (2018-2023)
7.15.5 Biotemed Key News & Latest Developments
7.16 Hangzhou Singclean Medical Products
7.16.1 Hangzhou Singclean Medical Products Company Summary
7.16.2 Hangzhou Singclean Medical Products Business Overview
7.16.3 Hangzhou Singclean Medical Products Surgical Hemostatic Material Major Product Offerings
7.16.4 Hangzhou Singclean Medical Products Surgical Hemostatic Material Sales and Revenue in Global (2018-2023)
7.16.5 Hangzhou Singclean Medical Products Key News & Latest Developments
8 Global Surgical Hemostatic Material Production Capacity, Analysis
8.1 Global Surgical Hemostatic Material Production Capacity, 2018-2029
8.2 Surgical Hemostatic Material Production Capacity of Key Manufacturers in Global Market
8.3 Global Surgical Hemostatic Material Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Surgical Hemostatic Material Supply Chain Analysis
10.1 Surgical Hemostatic Material Industry Value Chain
10.2 Surgical Hemostatic Material Upstream Market
10.3 Surgical Hemostatic Material Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Surgical Hemostatic Material Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(MMG23LY8064 )"外科用止血材のグローバル市場展望 2023年-2029年:止血ガーゼ、ゼラチンスポンジ、止血剤" (英文:Surgical Hemostatic Material Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。